Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS)
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Control ovarian stimulation responses, pregnancy and miscarriage rates are indifferent when
either recombinant or highly purified follicle stimulating hormone (FSH) is used.
Phase:
Phase 2
Details
Lead Sponsor:
Genesis Center for Fertility & Human Pre-Implantation Genetics